Monday, November 14, 2005

AVAN Avian Flu Vaccine

(AVAN1.70, +0.24, +16.4%) plans to pursue the development of an avian flu vaccine. The Needhma, Mass.-based Avant formed a research team to focus on the development, which will partly utilize the company's proprietary bacterial vectoring technologies and VitriLife preservation processes.

Hey if it works out, they could make alot of money!

This is not penny stocks investment advice

No comments: